New series of guidance and resources promote equitable access to quality care for all OTTAWA, ON – Everyone in Canada deserves a health system that provides each of us with… Read More
On September 26th, the Celltechna Gene Therapy Centre officially opened in Vilnius, marking a major milestone in Lithuania’s journey toward becoming a biotechnology leader. The centre is dedicated to researching… Read More
Phase 3 data on investigational vanza triple demonstrates non-inferiority to TRIKAFTA® in ppFEV1 and further improvement of CFTR function as measured by sweat chloride Real-world evidence and clinical studies of TRIKAFTA®… Read More
TORONTO, ON – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that Health Canada has accepted for review its New Drug Submission (NDS) for vanzacaftor/tezacaftor/deutivacaftor, a once-daily triple combination therapy for people living… Read More
SYRACUSE, NY, VANCOUVER, BC & BASEL, CH —Repair Biotechnologies, a biotechnology company developing first-in-class therapies capable of rapidly regressing atherosclerotic plaque, and Genevant Sciences, a leading nucleic acid delivery company… Read More
